BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21697077)

  • 1. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.
    Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause-Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study.
    Lai HTM; de Oliveira Otto MC; Lee Y; Wu JHY; Song X; King IB; Psaty BM; Lemaitre RN; McKnight B; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2019 Nov; 8(22):e012881. PubMed ID: 31711385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
    Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
    Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese.
    Zong G; Zhu J; Sun L; Ye X; Lu L; Jin Q; Zheng H; Yu Z; Zhu Z; Li H; Sun Q; Lin X
    Am J Clin Nutr; 2013 Aug; 98(2):319-26. PubMed ID: 23803879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest.
    Lemaitre RN; King IB; Sotoodehnia N; Knopp RH; Mozaffarian D; McKnight B; Rea TD; Rice K; Friedlander Y; Lumley TS; Raghunathan TE; Copass MK; Siscovick DS
    Metabolism; 2010 Jul; 59(7):1029-34. PubMed ID: 20045147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
    Wu JH; Lemaitre RN; Manichaikul A; Guan W; Tanaka T; Foy M; Kabagambe EK; Djousse L; Siscovick D; Fretts AM; Johnson C; King IB; Psaty BM; McKnight B; Rich SS; Chen YD; Nettleton JA; Tang W; Bandinelli S; Jacobs DR; Browning BL; Laurie CC; Gu X; Tsai MY; Steffen LM; Ferrucci L; Fornage M; Mozaffarian D
    Circ Cardiovasc Genet; 2013 Apr; 6(2):171-83. PubMed ID: 23362303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: a nested case-control study within the Women's Health Initiative observational study.
    Matthan NR; Ooi EM; Van Horn L; Neuhouser ML; Woodman R; Lichtenstein AH
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25122663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort.
    Zhu Y; Vogelpohl FA; Heiner-Fokkema MR; Pranger IG; Minović I; Navis GJ; Bakker SJL; Riphagen IJ
    J Clin Lipidol; 2022; 16(5):658-666. PubMed ID: 35909048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
    Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
    Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
    Imamura F; Fretts AM; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Virtanen JK; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Chen YY; Wood AC; Del Gobbo LC; Djousse L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Riserus U; Robinson JG; Samieri C; Senn M; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Tuomainen TP; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JHY; Micha R; Lemaitre RN; Mozaffarian D; Forouhi NG
    PLoS Med; 2020 Jun; 17(6):e1003102. PubMed ID: 32530938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma phospholipid trans-fatty acids levels, cardiovascular diseases, and total mortality: the cardiovascular health study.
    Wang Q; Imamura F; Lemaitre RN; Rimm EB; Wang M; King IB; Song X; Siscovick D; Mozaffarian D
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25164946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort.
    Huang NK; Bůžková P; Matthan NR; Djoussé L; Hirsch CH; Kizer JR; Longstreth WT; Mukamal KJ; Lichtenstein AH
    J Am Heart Assoc; 2021 Mar; 10(6):e019135. PubMed ID: 33682438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of dairy fatty acids and risk of cardiovascular disease in the Multi-ethnic Study of Atherosclerosis.
    de Oliveira Otto MC; Nettleton JA; Lemaitre RN; Steffen LM; Kromhout D; Rich SS; Tsai MY; Jacobs DR; Mozaffarian D
    J Am Heart Assoc; 2013 Jul; 2(4):e000092. PubMed ID: 23868191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary Saturated Fatty Acids and Coronary Heart Disease Risk in a Dutch Middle-Aged and Elderly Population.
    Praagman J; de Jonge EA; Kiefte-de Jong JC; Beulens JW; Sluijs I; Schoufour JD; Hofman A; van der Schouw YT; Franco OH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2011-8. PubMed ID: 27417581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding.
    Chong MF; Hodson L; Bickerton AS; Roberts R; Neville M; Karpe F; Frayn KN; Fielding BA
    Am J Clin Nutr; 2008 Apr; 87(4):817-23. PubMed ID: 18400702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS).
    Qureshi W; Santaren ID; Hanley AJ; Watkins SM; Lorenzo C; Wagenknecht LE
    BMJ Open Diabetes Res Care; 2019; 7(1):e000691. PubMed ID: 31543975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease.
    Djoussé L; Matthan NR; Lichtenstein AH; Gaziano JM
    Am J Cardiol; 2012 Aug; 110(4):539-44. PubMed ID: 22579341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fatty acids and risk of coronary heart disease in men: the Kuopio Ischemic Heart Disease Risk Factor Study.
    Virtanen JK; Mursu J; Tuomainen TP; Voutilainen S
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2679-87. PubMed ID: 25256234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study.
    Hamazaki K; Iso H; Eshak ES; Ikehara S; Ikeda A; Iwasaki M; Hamazaki T; Tsugane S;
    Atherosclerosis; 2018 May; 272():226-232. PubMed ID: 29277442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.